Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
SpartanNash Company (NASDAQ:SPTN) announced Friday that the 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its proposed merger with C&S Wholesale Grocers expired on Thursday without action by the U.S. Federal Trade Commission. The expiration of this waiting period satisfies a key regulatory condition for the transaction.
According to the company’s statement, the merger agreement was previously disclosed on June 22, 2025. Under the terms, Mackinac Merger Sub, Inc., a wholly owned subsidiary of New Mackinac HoldCo, Inc., will merge with and into SpartanNash, with SpartanNash surviving as a wholly owned subsidiary of the parent company. C&S Wholesale Grocers, LLC is acting as guarantor in the transaction.
C&S previously withdrew its initial Hart-Scott-Rodino filing on August 18, 2025, and resubmitted the notification on August 19, 2025. The new 30-day waiting period expired at 11:59 p.m. Thursday, with no action taken by the FTC.
SpartanNash stated it expects the closing of the transaction to occur on or about September 22, 2025, subject to the satisfaction of other customary closing conditions.
The information in this article is based on a press release statement included in a recent SEC filing.
In other recent news, SpartanNash reported second-quarter earnings that surpassed analyst expectations. This performance was attributed to improved gross margins and contributions from recent acquisitions. In another development, SpartanNash announced that C&S Wholesale Grocers has voluntarily withdrawn and resubmitted its Hart-Scott-Rodino Antitrust Notification and Report Form concerning their planned merger. This action is intended to provide the Federal Trade Commission with additional time to review the proposed transaction. The original filing was made on July 18, 2025, and the resubmission restarts the standard 30-day antitrust waiting period. SpartanNash emphasized that this withdrawal and refiling is a routine procedure for regulatory review. These recent developments come as the company continues to navigate the complexities of mergers and regulatory processes.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.